Stephen L. Sabba is Director at LIGAND PHARMACEUTICALS INC (LGND). They have made 13 open-market trades across 1 company since 2011, most recently 2026-06-16.
CIK 0001442372
2 open-market purchases totalling $109K since 2011, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LGND | 33,629 | $9.9M |
| QLTI | 24,500 | $644K |
| Total | $10.6M |
Shares reported on the most recent Form 4, priced at the 2026-06-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LGND | SELL | 2026-06-16 | 2026-06-18 | $254.00 | $545K | +15.3% | +8.8% | +1.8% |
| LGND | SELL | 2026-03-23 | 2026-03-25 | $207.87 | $416K | +0.1% | +12.8% | +36.5% |
| LGND | SELL | 2026-03-03 | 2026-03-05 | $201.50 | $410K | +4.2% | +0.5% | +15.5% |
| LGND | SELL | 2024-03-05 | 2024-03-07 | $74.30 | $281K | -1.2% | +9.0% | +14.4% |
| LGND | SELL | 2023-05-10 | 2023-05-12 | $77.13 | $988K | -1.9% | -2.6% | -9.6% |
| LGND | SELL | 2021-02-09 | 2021-02-11 | $208.54 | $6.0M | -18.4% | -8.9% | -30.1% |
| LGND | SELL | 2019-07-31 | 2019-08-01 | $94.45 | $773K | -0.0% | -7.4% | +17.7% |
| LGND | SELL | 2018-09-04 | 2018-09-06 | $255.05 | $1.3M | +6.2% | -1.2% | -38.6% |
| LGND | SELL | 2018-03-12 | 2018-03-13 | $180.73 | $225K | -10.0% | -6.6% | +7.5% |
| LGND | SELL | 2017-12-20 | 2017-12-21 | $137.25 | $254K | +4.4% | +17.3% | +22.7% |
| LGND | BUY | 2014-10-09 | 2014-10-14 | $43.12 | $86K | -9.9% | -3.4% | -3.4% |
| LGND | SELL | 2014-02-27 | 2014-02-28 | $72.25 | $36K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2011-11-10 | 2011-11-14 | $11.60 | $23K | -9.9% | -3.4% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.